Literature DB >> 20072798

Lung abscess and pleuritis caused by Lactobacillus rhamnosus in an immunocompetent patient.

Hisashi Shoji1, Koichiro Yoshida, Yoshihito Niki.   

Abstract

A 79-year-old man consulted us because of left chest pain and fever ranging from 38.0 to 38.9 °C. A chest computed tomography scan showed a mass lesion (φ40 mm) in the left lingular segment, and inflammatory markers were elevated. He was admitted with a diagnosis of lung abscess, and panipenem/betamipron was administered at a dose of 2 g/day, after which the symptoms showed slight transient resolution. However, his body temperature increased again, to more than 39.0 °C, on the eighth day of hospitalization, and a chest radiograph suggested pleuritis as a complication. The antibiotics were changed to teicoplanin (TEIC; 400 mg/day) and meropenem (2.0 g/day). Thoracic drainage and pleural lavage were initiated at the same time. Lactobacillus spp. was detected from the pleural effusion by culture and was considered to be the causative organism, and it was resistant to TEIC. Therefore, the antibiotic was changed, to clindamycin, to which the bacteria was susceptible. No subsequent fever or pleural fluid retention was observed. The patient’s course was good, and he was discharged on day 45 of hospitalization. Subsequently, the causative organism was identified as Lactobacillus rhamnosus by the 16s rRNA sequence. Lactobacillus rhamnosus is rarely pathogenic in humans. Lactobacillus rhamnosus infection mostly occurs in immunosuppressed patients, and only a few cases have been reported in immunocompetent patients. In the present case, the patient was not immunodeficient; however, his lung had an impaired local immunosystem, due to emphysema.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20072798     DOI: 10.1007/s10156-009-0004-5

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  8 in total

1.  Lactobacillus rhamnosus bacteremia: an emerging clinical entity.

Authors:  F Gouriet; M Million; M Henri; P-E Fournier; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-04-28       Impact factor: 3.267

2.  Pulmonary actinomycosis and polymicrobial empyema in a patient with ABPA and bronchocoele.

Authors:  Jacky Tu; Martin MacDonald; Darren Mansfield
Journal:  Respirol Case Rep       Date:  2022-05-01

3.  Clinical insights from metagenomic analysis of sputum samples from patients with cystic fibrosis.

Authors:  Yan Wei Lim; Jose S Evangelista; Robert Schmieder; Barbara Bailey; Matthew Haynes; Mike Furlan; Heather Maughan; Robert Edwards; Forest Rohwer; Douglas Conrad
Journal:  J Clin Microbiol       Date:  2013-11-20       Impact factor: 5.948

4.  Molecular analysis and clinical significance of Lactobacillus spp. recovered from clinical specimens presumptively associated with disease.

Authors:  Raquel M Martinez; Kristina G Hulten; Uyen Bui; Jill E Clarridge
Journal:  J Clin Microbiol       Date:  2013-10-16       Impact factor: 5.948

5.  High-throughput RNA sequencing of a formalin-fixed, paraffin-embedded autopsy lung tissue sample from the 1918 influenza pandemic.

Authors:  Yong-Li Xiao; John C Kash; Stephen B Beres; Zong-Mei Sheng; James M Musser; Jeffery K Taubenberger
Journal:  J Pathol       Date:  2013-03       Impact factor: 7.996

6.  Pneumonia and Pleural Empyema due to a Mixed Lactobacillus spp. Infection as a Possible Early Esophageal Carcinoma Signature.

Authors:  Eleftheria Chaini; Nikolaos D Chainis; Anastasios Ioannidis; Maria Magana; Chryssoula Nikolaou; Joseph Papaparaskevas; Melina-Vassiliki Liakata; Panagiotis Katopodis; Leonidas Papastavrou; George P Tegos; Stylianos Chatzipanagiotou
Journal:  Front Med (Lausanne)       Date:  2016-09-28

7.  Lactobacillus gasseri Causing Bilateral Empyema.

Authors:  Angela Esquibel; Ala S Dababneh; Bharath Raj Palraj
Journal:  Case Rep Infect Dis       Date:  2017-09-25

8.  Descending necrotizing mediastinitis associated with Lactobacillus plantarum.

Authors:  Takahito Nei; Shunta Inai; Iwao Mikami; Akira Sato; Junichi Okamoto; Kazuhiko Yokoshima; Munenaga Nakamizo; Shuji Haraguchi; Kazunari Sonobe; Ryoichi Saito
Journal:  BMC Infect Dis       Date:  2013-08-29       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.